Quality of care for major depression and its determinants: a multilevel analysis

BMC Psychiatry

Pasquale Roberge¹  Lise Gauvin²  Louise Fournier³  Arnaud Duhoux³ 

[1]Université de Sherbrooke, 3001, 12e Avenue Nord, J1H 5 N4, Sherbrooke, QC, Canada

[2]Université de Montréal, C.P. 6128, succursale Centre-ville, H3C 3 J7, Montreal, QC, Canada

[3]Institut National de Santé Publique du Québec, 190 Crémazie Blvd. East, H2P 1E2, Montreal, QC, Canada

关键词: Multilevel analysis;    Adequacy of treatment;    Major depressive episode;    Quality indicator;    Quality of care;   

Others  :  1124289
DOI  :  10.1186/1471-244X-12-142

 received in 2012-03-23, accepted in 2012-08-09,  发布年份 2012

【 摘 要 】

Background

Numerous studies highlight an important gap in the quality of care for depression in primary care. However, basic indicators were often used. Few of these studies examined factors associated with receiving adequate treatment, particularly with a simultaneous consideration of individual and organizational characteristics. The purpose of this study was to estimate the proportion of primary care patients with a major depressive episode (MDE) who receive adequate treatment and to examine the individual and organizational (i.e., clinic-level) characteristics associated with the receipt of at least one minimally adequate treatment for depression.

Methods

The sample used for this study included 915 adults consulting a general practitioner (GP), regardless of the motive of consultation, meeting DSM-IV criteria for MDE during the 12 months preceding the survey (T1), and nested within 65 primary care clinics. Data reported in this study were obtained from the “Dialogue” project. Adherence rates for 27 quality indicators selected to cover the most important components of depression treatment were estimated. Multilevel analyses were conducted.

Results

Adherence to guidelines was high (>75%) for one third of the quality indicators that were measured but was low (<60%) for nearly half of the measures. Just over half of the sample (52.2%) received at least one minimally adequate treatment for depression. At the individual level, determinants of receipt of minimally adequate care included age, having a family physician, a supplementary insurance coverage, a comorbid anxiety disorder and the severity of depression. At the clinic level, determinants included the availability of psychotherapy on-site, the use of treatment algorithms, and the mode of remuneration.

Conclusions

Our findings suggest that interventions are needed to increase the extent to which primary mental health care conforms to evidence-based recommendations. These interventions should target specific populations (i.e. the younger adults and the elderly), enhance accessibility to psychotherapy and to a regular family physician, and support primary care physicians in their clinical practice with patients suffering from depression in different ways such as developing knowledge to treat depression and adapting mode of remuneration.

【 授权许可】

   
2012 Duhoux et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Patten SB, Wang JL, Williams JVA, Currie S, Beck CA, Maxwell CJ, el-Guebaly N: Descriptive Epidemiology of Major Depression in Canada. Can J Psychiatry 2006, 51:84-90.
• [2]WHO: The global burden of disease: 2004 update. Geneva: World Health Organization; 2008.
• [3]Patten SB, Kennedy SH, Lam RW, O'Donovan C, Filteau MJ, Parikh SV, Ravindran AV: Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. I. Classification, burden and principles of management. J Affect Disord 2009, 117(Suppl 1):S5-S14.
• [4]WHO: The world health report 2001 - Mental Health: New Understanding, New Hope. Geneva: World Health Organization; 2001.
• [5]Pincus HA, Pechura CM, Elinson L, Pettit AR: Depression in primary care: linking clinical and systems strategies. Gen Hosp Psychiatry 2001, 23:311-318.
• [6]Gilbody SM, Whitty PM, Grimshaw JM, Thomas RE: Improving the detection and management of depression in primary care. Qual Saf Health Care 2003, 12:149-155.
• [7]Duhoux A, Fournier L, Nguyen CT, Roberge P, Beveridge R: Guideline concordance of treatment for depressive disorders in Canada. Soc Psychiatry Psychiatr Epidemiol 2009, 44:385-392.
• [8]Wells KB, Sherbourne C, Schoenbaum M, Duan N, Meredith L, Unutzer J, Miranda J, Carney MF, Rubenstein LV: Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial. JAMA 2000, 283:212-220.
• [9]Asarnow JR, Jaycox LH, Duan N, LaBorde AP, Rea MM, Murray P, Anderson M, Landon C, Tang L, Wells KB: Effectiveness of a quality improvement intervention for adolescent depression in primary care clinics: a randomized controlled trial. JAMA 2005, 293:311-319.
• [10]Hepner KA, Rowe M, Rost K, Hickey SC, Sherbourne CD, Ford DE, Meredith LS, Rubenstein LV: The effect of adherence to practice guidelines on depression outcomes. Ann Intern Med 2007, 147:320-329.
• [11]Rost K, Williams C, Wherry J, Smith GR Jr: The process and outcomes of care for major depression in rural family practice settings. J Rural Health 1995, 11:114-121.
• [12]Sturm R, Wells KB: How can care for depression become more cost-effective? JAMA 1995, 273:51-58.
• [13]Melfi CA, Chawla AJ, Croghan TW, Hanna MP, Kennedy S, Sredl K: The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. Arch Gen Psychiatry 1998, 55:1128-1132.
• [14]Sood N, Treglia M, Obenchain RL, Dulisse B, Melfi CA, Croghan TW: Determinants of antidepressant treatment outcome. Am J Manag Care 2000, 6:1327-1336.
• [15]Pyne JM, Rost KM, Zhang M, Williams DK, Smith J, Fortney J: Cost-effectiveness of a primary care depression intervention. J Gen Intern Med 2003, 18:432-441.
• [16]American Psychiatric Association: Practice guideline for major depressive disorder in adults. Am J Psychiatry 1993, 150:1-26.
• [17]AHCPR Depression Guideline Panel: Clinical Practice Guideline Number 5. Depression in Primary Care: Vol. 2. In Treatment of Major Depression. AHCPR Pub. No. 93-0551. Rockville, MD. DC: Agency for Healthcare Policy and Research. Public Health Services: US Department of Health and Human Services, Washington; 1993.
• [18]British Association for Psychopharmacology: Guidelines for treating depressive illness with antidepressants. J Psychopharmacol 1993, 7:19-23.
• [19]Canadian Psychiatric Association; Canadian Network for Mood and Anxiety Treatments (CANMAT): Clinical guidelines for the treatment of depressive disorders. Can J Psychiatry 2001, 46:5S-90S.
• [20]Ellis P: Australian and New Zealand clinical practice guidelines for the treatment of depression. Aust N Z J Psychiatry 2004, 38:389-407.
• [21]National Institute for Clinical Excellence: Depression: Management of Depression in Primary and Secondary Care. Clinical Guideline. London: NICE; 2004.
• [22]Brugha TS, Lindsay F: Quality of mental health service care: the forgotten pathway from process to outcome. Soc Psychiatry Psychiatr Epidemiol 1996, 31:89-98.
• [23]Tugwell P: A methodological perspective on process measures of the quality of medical care. Clin Invest Med 1979, 2:113-121.
• [24]Donabedian A: Evaluating the quality of medical care. Milbank Mem Fund Q 1966, 44(Suppl):166-206.
• [25]Charbonneau A, Rosen AK, Owen RR, Spiro A 3rd, Ash AS, Miller DR, Kazis L, Kader B, Cunningham F, Berlowitz DR: Monitoring depression care: in search of an accurate quality indicator. Med Care 2004, 42:522-531.
• [26]Micossi P, Carbone M, Stancanelli G, Fortino A: Measuring products of healthcare systems. Lancet 1993, 341:1566-1567.
• [27]Hermann RC, Palmer RH: Common ground: a framework for selecting core quality measures for mental health and substance abuse care. Psychiatr Serv 2002, 53:281-287.
• [28]Duhoux A, Fournier L, Menear M: Quality Indicators for Depression Treatment in Primary Care: A Systematic Literature Review. Current Psychiatry Reviews 2011, 7:104-137.
• [29]Andersen RM, Newman JF: Societal and individual determinants of medical care utilization in the United States. Milbank Memorial Fund Quarterly 1973, 51:95-124.
• [30]Starkes JM, Poulin CC, Kisely SR: Unmet need for the treatment of depression in Atlantic Canada. Can J Psychiatry 2005, 50:580-590.
• [31]Katz SJ, Kessler RC, Lin E, Wells KB: Medication management of depression in the United States and Ontario. J Gen Intern Med 1998, 13:77-85.
• [32]Prins MA, Verhaak PF, Smolders M, Laurant MG, van der Meer K, Spreeuwenberg P, van Marwijk HW, Penninx BW, Bensing JM: Patient factors associated with guideline-concordant treatment of anxiety and depression in primary care. J Gen Intern Med 2010, 25:648-655.
• [33]Dickinson LM, Dickinson WP, Rost K, DeGruy F, Emsermann C, Froshaug D, Nutting PA, Meredith L: Clinician burden and depression treatment: disentangling patient- and clinician-level effects of medical comorbidity. J Gen Intern Med 2008, 23:1763-1769.
• [34]Smolders M, Laurant M, Verhaak P, Prins M, van Marwijk H, Penninx B, Wensing M, Grol R: Which physician and practice characteristics are associated with adherence to evidence-based guidelines for depressive and anxiety disorders? Med Care 2010, 48:240-248.
• [35]Dialogue Project. http://www.qualaxia.org/ms/dialogue/index.php?lg=en webcite
• [36]World Medical Association (WMA): WMA Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects. http://www.wma.net/en/30publications/10policies/b3/index.html webcite
• [37]Pineault R, Levesque J-F, Roberge D, Hamel M, Lamarche P, Haggerty J: L’accessibilité et la continuité des services de santé: une étude sur la première ligne au Québec. Montreal: Centre de recherche de l'Hôpital Charles LeMoyne - Agence de la santé et des services sociaux de Montréal-Direction de la santé publique - Institut national de santé publique du Québec; 2008.
• [38]Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand 1983, 67:361-370.
• [39]Bjelland I, Dahl AA, Haug TT, Neckelmann D: The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002, 52:69-77.
• [40]Cameron IM, Crawford JR, Lawton K, Reid IC: Psychometric comparison of PHQ-9 and HADS for measuring depression severity in primary care. Br J Gen Pract 2008, 58:32-36.
• [41]Kovess V, Fournier L, Lesage A, Lebigre F, Caria A: Two validation studies of the CIDIS: a simplified version of the Composite International Diagnostic Interview. Psychiatric Networks 2001, 4:10-24.
• [42]American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 4th edition. DC: American Psychiatric Association, Washington; 1994.
• [43]Raudenbush S, Bryk A: Hierarchical linear models: Applications and data analysis methods. 2nd edition. CA: Sage, Thousand Oaks; 2002.
• [44]Dobscha SK, Gerrity MS, Corson K, Bahr A, Cuilwik NM: Measuring adherence to depression treatment guidelines in a VA primary care clinic. Gen Hosp Psychiatry 2003, 25:230-237.
• [45]Henke RM, McGuire TG, Zaslavsky AM, Ford DE, Meredith LS, Arbelaez JJ: Clinician- and organization-level factors in the adoption of evidence-based care for depression in primary care. Health Care Manage Rev 2008, 33:289-299.
• [46]Smolders M, Laurant M, Roberge P, Akkermans R, Wensing M, Grol R: How well do GPs fulfill their educator role in consultations for depression and anxiety? Patient Educ Couns 2008, 73:389-395.
• [47]Herring MP, Puetz TW, O'Connor PJ, Dishman RK: Effect of Exercise Training on Depressive Symptoms Among Patients With a Chronic Illness: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Arch Intern Med 2012, 172:101-111.
• [48]Harvey SB, Hotopf M, Overland S, Mykletun A: Physical activity and common mental disorders. Br J Psychiatry 2010, 197:357-364.
• [49]Mead GE, Morley W, Campbell P, Greig CA, McMurdo M, Lawlor DA: Exercise for depression. Cochrane Database Syst Rev 2008. Issue 4. Art. No.: CD004366
• [50]Pinto-Meza A, Fernandez A, Serrano-Blanco A, Haro JM: Adequacy of antidepressant treatment in Spanish primary care: a naturalistic six-month follow-up study. Psychiatr Serv 2008, 59:78-83.
• [51]Charbonneau A, Rosen AK, Ash AS, Owen RR, Kader B, Spiro A 3rd, Hankin C, Herz LR, Jo VPM, Kazis L, et al.: Measuring the quality of depression care in a large integrated health system. Med Care 2003, 41:669-680.
• [52]Spettell CM, Wall TC, Allison J, Calhoun J, Kobylinski R, Fargason R, Kiefe CI: Identifying physician-recognized depression from administrative data: consequences for quality measurement. Health Serv Res 2003, 38:1081-1102.
• [53]Cully JA, Zimmer M, Khan MM, Petersen LA: Quality of depression care and its impact on health service use and mortality among veterans. Psychiatr Serv 2008, 59:1399-1405.
• [54]Simon GE, Von Korff M, Rutter CM, Peterson DA: Treatment process and outcomes for managed care patients receiving new antidepressant prescriptions from psychiatrists and primary care physicians. Arch Gen Psychiatry 2001, 58:395-401.
• [55]Olfson M, Marcus SC, Druss B, Elinson L, Tanielian T, Pincus HA: National trends in the outpatient treatment of depression. JAMA 2002, 287:203-209.
• [56]Rollman BL, Hanusa BH, Lowe HJ, Gilbert T, Kapoor WN, Schulberg HC: A randomized trial using computerized decision support to improve treatment of major depression in primary care. J Gen Intern Med 2002, 17:493-503.
• [57]Harman JS, Edlund MJ, Fortney JC: Disparities in the adequacy of depression treatment in the United States. Psychiatr Serv 2004, 55:1379-1385.
• [58]Young AS, Klap R, Sherbourne CD, Wells KB: The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psychiatry 2001, 58:55-61.
• [59]Wang PS, Aguilar-Gaxiola S, Alonso J, Angermeyer MC, Borges G, Bromet EJ, Bruffaerts R, de Girolamo G, de Graaf R, Gureje O, et al.: Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys. Lancet 2007, 370:841-850.
• [60]Prins MA, Verhaak PF, van der Meer K, Penninx BW, Bensing JM: Primary care patients with anxiety and depression: need for care from the patient's perspective. J Affect Disord 2009, 119:163-171.
• [61]Statistics Canada: Table 105–3024 - Population reporting a regular family physician, household population aged 15 and over, Canada, provinces and territories, occasional, CANSIM (database). http://www5.statcan.gc.ca/cansim/a01?lang=eng webcite
• [62]Wang PS, Berglund P, Kessler RC: Recent care of common mental disorders in the United States : prevalence and conformance with evidence-based recommendations. J Gen Intern Med 2000, 15:284-292.
• [63]Lagomasino IT, Dwight-Johnson M, Miranda J, Zhang L, Liao D, Duan N, Wells KB: Disparities in depression treatment for Latinos and site of care. Psychiatr Serv 2005, 56:1517-1523.
• [64]Enns MW, Swenson JR, McIntyre RS, Swinson RP, Kennedy SH: Clinical guidelines for the treatment of depressive disorders. VII. Comorbidity. Can J Psychiatry 2001, 46(Suppl 1):77S-90S.
• [65]Grolleau A, Cougnard A, Begaud B, Verdoux H: Congruence between diagnosis of recurrent major depressive disorder and psychotropic treatment in the general population. Acta Psychiatr Scand 2008, 117:20-27.
• [66]Richards DA, Borglin G: Implementation of psychological therapies for anxiety and depression in routine practice: two year prospective cohort study. J Affect Disord 2011, 133:51-60.
• [67]Shafran R, Clark DM, Fairburn CG, Arntz A, Barlow DH, Ehlers A, Freeston M, Garety PA, Hollon SD, Ost LG, et al.: Mind the gap: Improving the dissemination of CBT. Behav Res Ther 2009, 47:902-909.
• [68]Nutting PA, Rost K, Dickinson M, Werner JJ, Dickinson P, Smith JL, Gallovic B: Barriers to initiating depression treatment in primary care practice. J Gen Intern Med 2002, 17:103-111.
• [69]Shipman C, Addington-Hall J, Barclay S, Briggs J, Cox I, Daniels L, Millar D: How and why do GPs use specialist palliative care services? Palliat Med 2002, 16:241-246.
• [70]Kravitz RL, Franks P, Feldman M, Meredith LS, Hinton L, Franz C, Duberstein P, Epstein RM: What drives referral from primary care physicians to mental health specialists? A randomized trial using actors portraying depressive symptoms. J Gen Intern Med 2006, 21:584-589.
• [71]Arean PA, Alvidrez J, Feldman M, Tong L, Shermer R: The role of provider attitudes in prescribing antidepressants to older adults: leverage points for effective provider education. Int J Psychiatry Med 2003, 33:241-256.
• [72]Geneau R, Lehoux P, Pineault R, Lamarche P: Understanding the work of general practitioners: a social science perspective on the context of medical decision making in primary care. BMC Fam Pract 2008, 9:12. BioMed Central Full Text
• [73]Shen J, Andersen R, Brook R, Kominski G, Albert PS, Wenger N: The effects of payment method on clinical decision-making: physician responses to clinical scenarios. Med Care 2004, 42:297-302.
• [74]Wagner EH: Chronic disease management: what will it take to improve care for chronic illness? Eff Clin Pract 1998, 1:2-4.
• [75]Drapeau A, Boyer R, Diallo FB: Discrepancies between survey and administrative data on the use of mental health services in the general population: findings from a study conducted in Quebec. BMC Public Health 2011, 11:837. BioMed Central Full Text
• [76]Saunders K, Simon G, Bush T, Grothaus L: Assessing the feasibility of using computerized pharmacy refill data to monitor antidepressant treatment on a population basis: a comparison of automated and self-report data. J Clin Epidemiol 1998, 51:883-890.
• [77]Kwon A, Bungay KM, Pei Y, Rogers WH, Wilson IB, Zhou Q, Adler DA: Antidepressant use: concordance between self-report and claims records. Med Care 2003, 41:368-374.